1 / 15

The medium is the message: public engagement, value and bias

The medium is the message: public engagement, value and bias. Dean A Regier, PhD Cancer Control Research, BC Cancer Agency Assistant Professor, School of Population and Public Health, University of British Columbia. 2015 CADTH Symposium Saskatoon, Saskatchewan. Public Engagement & Value.

bettyb
Télécharger la présentation

The medium is the message: public engagement, value and bias

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. The medium is the message: public engagement, value and bias Dean A Regier, PhD Cancer Control Research, BC Cancer Agency Assistant Professor, School of Population and Public Health, University of British Columbia 2015 CADTH Symposium Saskatoon, Saskatchewan

  2. Public Engagement & Value Problem #1 • Input from the public is not routinely pursued in health-care decision-making • Public values viewed as biased Problem #2 • Public values are (probably) biased • Leads to misallocation of scarce resources

  3. Why Public Engagement? Involving the public in policy-forming activities • Public includes patient/lay public Normative & pragmatic motivations • Democratic ideals; economic theory • Comparative-effectiveness

  4. Relative to clinical effectiveness and cost • Input from the public is rarely pursued • Barriers • Implies public input is biased *Regier DA, Bentley C, Mitton C, et al. Public Engagement in Priority-Setting: Results from a pan-Canadian Survey of Decision-Makers in Cancer Control. Social Science & Medicine; 2014: 122:130-139.

  5. Public Engagement & Bias Stated preference elicitation of utility Non-market valuation of goods Hypothetical bias Benefit over-valuation leads to investing in goods that cost too much in terms of available alternatives Mitigating hypothetical bias Rationality tests; cheap-talk; oath

  6. Communication theory The medium is the message - McLuhan, 1964 • The medium delivers change separate from content • Hypothesis: a video introduction to a stated preference study will differently engage respondents and mitigate hypothetical bias

  7. Background Next generation genomic sequencing • Predictive therapy, prognostic therapy, hereditary cause of disease Potential of incidental findings • Information on diseases not related to current diagnosis

  8. ACMG Recommendations Published list of incidental findings (Green et al, 2013) • High-penetrance & clinical utility • List of 56 genes, 24 disorders • Labs look for mutations, IF’s returned to patient, through managing physician Controversial • Patients not offered a choice • (Public not consulted)

  9. Objective & Sample Objective • Personal utility for the return incidental findings • Discrete choice experiment (two choice + opt-out) Respondent Sample • General public in Canada (N=1200) • English and French language versions

  10. Methods Approach Define Attributes/levels • Cognitive interviews (n=6)/ 2 focus groups (n=12) Experimental design • D-efficient design with informative priors Statistical Analysis • Mixed Logit Model (preference heterogeneity) Welfare analysis • Willingness to pay (compensating variation)

  11. Study design D1 Video Introduction & Text Intro D2 Evaluate difference in welfare estimates English-speaking Respondents randomized randomized D3 Text Introduction Only D4

  12. Choice task example

  13. Welfare Analysis • Lower WTP values in video version • Potential to mitigate hypothetical bias

  14. Questions • Is it necessary for decision-makers to consult the public for each health care investment/disinvestment decisions? • Willingness to pay (and utility) is often biased, is there a role for this metric in decision-making? • Focus on naturalistic units? • Do researchers need do more with how the public is engaged?

  15. Thank-you • Funding for this research obtained from the Canadian Centre for Applied Research in Cancer Control (ARCC); ARCC is funded by the Canadian Cancer Society Research Institute grant #019789, #703549 • Acknowledgements: Stuart Peacock, Reka Pataky, Kimberly van der Hoek, Gail Jarvik, Jeffrey Hoch, David Veenstra

More Related